The Effects of Insomnia Treatment on Overnight Regulation of Emotional Memories and Risk for Mental Disorders

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-45
SponsorWoolcock Institute of Medical Research

About this trial

This project aims to elucidate whether CBCTi changes symptom severity or even remission of anxiety disorders as compared with a delayed-start control group. The investigators will use a delayed-start randomized controlled trial in a cohort of individuals with anxiety and insomnia (N=98) to compare the effects of an online therapist-guided cognitive behavioural and circadian therapy for insomnia versus control on overnight emotion regulation and mental health outcomes.

The project will involve at-home assessments and in-lab visits. At-home assessment involves recording sleep and circadian rhythm measures with wearables and daily diaries. Participants will be invited to perform two sleep studies and neuroimaging sessions to investigate the effects of CBCTi on neuroimaging and psychophysiological markers of overnight regulation of emotional distress.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

(A or B) and (C) A. Diagnosis of insomnia disorder (DSM-5-TR) B. Insomnia Severity Index (ISI) score ≥ 10 C. Generalized Anxiety Disorder (GAD-7) score ≥ 10

All sexes and genders.

Between 18 and 45 years of age.

Able to provide informed consent.

Disqualifiers

Current or history of neurological disorders (e.g., stroke, brain injury).

Current or history of bipolar disorder, psychosis, or moderate to severe obsessive-compulsive disorder.

Current uncontrolled mental health disorders requiring specialist care, other than major depression and anxiety disorders.

Centrally active agents or presence of medical condition that may affect participation.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Immediate CBCTi

    Behavioral

    This intervention will be immediately accessible to the CBCTi group. The program is composed of weekly online modules that include written information and interactive components such as schematics, images, videos, and questions. The content of the modules follows traditional and validated cognitive-behavioural therapy for insomnia protocols including sleep education, behavioural strategies (e.g., stimulus control, bedtime retraining, sleep hygiene), cognitive restructuration approaches (e.g., thought reappraisal, imagery, mindfulness), and relaxation practices (progressive muscle relaxation and autogenic training). In addition, further content aims to stabilize and amplify circadian rhythmicity through light exposure in the morning, daytime moderate physical activity, and evening time warm baths. Participants complete daily sleep diaries throughout the intervention.

  • Delayed CBCTi

    Behavioral

    This intervention will be accessible after a waiting period of 2 months (i.e, delayed start). The program is composed of weekly online modules that include written information and interactive components such as schematics, images, videos, and questions. The content of the modules follows traditional and validated cognitive-behavioural therapy for insomnia protocols including sleep education, behavioural strategies (e.g., stimulus control, bedtime retraining, sleep hygiene), cognitive restructuration approaches (e.g., thought reappraisal, imagery, mindfulness), and relaxation practices (progressive muscle relaxation and autogenic training). In addition, further content aims to stabilize and amplify circadian rhythmicity through light exposure in the morning, daytime moderate physical activity, and evening time warm baths. Participants complete daily sleep diaries throughout the intervention.

Treatment groups

98 Participants
are divided into 2 treatment groups
Group A: Immediate CBCTiExperimental treatment 1 intervention
Group B: Delayed-start controlOther 1 intervention

Trial outcomes

Primary outcomes

1

General Anxiety Disorder-7 (GAD-7) score

Self-report measures of anxiety symptoms and severity. GAD-7 consists of 7 Likert-scale questions with a total score ranging from 0 to 21 (with higher scores indicating more severe anxiety)

Time frame
2 months, 4 months, 12 months
2

Anxiety Disorder diagnosis

Clinician-diagnosed anxiety disorder in accordance with the DSM-5-TR using the Mini-International Neuropsychiatric Interview

Time frame
2 months, 4 months, 12 months

Secondary outcomes

1

Insomnia Severity Index (ISI) score

Self-report measures of insomnia symptoms and severity. ISI consists of 7 Likert-scale questions with a total score ranging from 0 to 28 (with higher scores indicating more severe insomnia)

Time frame
2 months, 4 months, 12 months
2

EEG sleep efficiency (SE - %)

Mean SE derived from at-home sleep recordings (total sleep time/time in bed\*100)

Time frame
2 months, 4 months, 12 months
3

EEG total sleep time (TST - minutes)

Mean TST derived from at-home sleep recordings

Time frame
2 months, 4 months, 12 months
4

EEG wake duration (minutes)

Mean wake after sleep onset (WASO) derived from at-home sleep recordings

Time frame
2 months, 4 months, 12 months

Other outcomes

1

Sleep electroencephalographic (EEG) spectral power

derived from polysomnographic (PSG) recordings in-lab: absolute and relative spectral power for band frequencies: slow oscillations (0.25-1.25Hz), delta (0.25-4Hz), theta (4.25-8Hz), alpha (8.25-11.75Hz), sigma (12-16Hz), low beta (16.25-19Hz), high beta (19.25-35Hz) for all stages.

Time frame
2 months
2

Sleep electroencephalographic (EEG) neuro-oscillatory coupling

derived from PSG recordings in-lab - phase-amplitude coupling measures (modulation index, preferred phase)

Time frame
2 months
3

Functional connectivity patterns in resting-state brain networks

measured by network-wise dual-regression independent component analysis (FMRIB FSL) with the whole-brain voxel-wise connectivity strength is the dependent variable

Time frame
2 months
4

EEG sleep-related brain oscillations (characteristics)

EEG neurophysiological events derived from PSG recordings in-lab : density, duration, peak frequency, amplitude, number

Time frame
2 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Woolcock Institute of Medical Research

Lead sponsor

Macquarie University, Australia

Collaborator